GPT-Rosalind is designed to support evidence synthesis, hypothesis generation, experimental planning, and multi-step scientific workflows across biochemistry, genomics, and protein engineering.
"This launch, at its core, is about taking our existing agents SDK and making it so it's compatible with all of these sandbox providers," Karan Sharma, who works on OpenAI's product team, told TechCrunch.